NORBERT W BISCHOFBERGER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NORBERT W BISCHOFBERGER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NORBERT W BISCHOFBERGER. NORBERT W BISCHOFBERGER is EVP, R&D and CSO in GILEAD SCIENCES INC ($GILD) and EVP, Research in GILEAD SCIENCES INC ($GILD) and SVP, Research in GILEAD SCIENCES INC ($GILD) and Director in Morphic Holding, Inc. ($MORF) and President & CEO in Kronos Bio, Inc. ($KRON).
Latest Insider Trading Transactions of NORBERT W BISCHOFBERGER
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GILD, KRON, MORF
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11 2020 | KRON | Kronos Bio, Inc. | BISCHOFBERGER NORBERT W | President & CEO | Option Exercise | A | 30.78 | 297,186 | 9,147,385 | 297,186 | |
| Dec 11 2020 | KRON | Kronos Bio, Inc. | BISCHOFBERGER NORBERT W | President & CEO | Grant | A | 0.00 | 198,124 | 0 | 198,124 | 0 to 198.1 K |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | BISCHOFBERGER NORBERT W | President & CEO | Option Exercise | C | 0.00 | 250,000 | 0 | 0 | |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | BISCHOFBERGER NORBERT W | President & CEO | Option Exercise | C | 0.00 | 250,000 | 0 | 0 | |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | BISCHOFBERGER NORBERT W | President & CEO | Option Exercise | C | 0.00 | 250,000 | 0 | 0 | |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | BISCHOFBERGER NORBERT W | President & CEO | Option Exercise | C | 0.00 | 250,000 | 0 | 0 | |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | BISCHOFBERGER NORBERT W | President & CEO | Option Exercise | C | 0.00 | 1,565,475 | 0 | 0 | |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | BISCHOFBERGER NORBERT W | President & CEO | Option Exercise | C | 0.00 | 300,001 | 0 | 0 | |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | BISCHOFBERGER NORBERT W | President & CEO | Buy | C | 0.00 | 263,750 | 0 | 263,750 | 0 to 263.8 K |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | BISCHOFBERGER NORBERT W | President & CEO | Buy | C | 0.00 | 263,750 | 0 | 263,750 | 0 to 263.8 K |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | BISCHOFBERGER NORBERT W | President & CEO | Buy | C | 0.00 | 263,750 | 0 | 263,750 | 0 to 263.8 K |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | BISCHOFBERGER NORBERT W | President & CEO | Buy | C | 0.00 | 263,750 | 0 | 263,750 | 0 to 263.8 K |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | BISCHOFBERGER NORBERT W | President & CEO | Buy | P | 19.00 | 95,500 | 1,814,500 | 4,370,496 | 4.3 M to 4.4 M (+2.23 %) |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | BISCHOFBERGER NORBERT W | President & CEO | Buy | C | 16.15 | 185,758 | 2,999,992 | 4,274,996 | 4.1 M to 4.3 M (+4.54 %) |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | BISCHOFBERGER NORBERT W | President & CEO | Buy | C | 0.00 | 1,651,576 | 0 | 4,089,238 | 2.4 M to 4.1 M (+67.75 %) |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | BISCHOFBERGER NORBERT W | President & CEO | Buy | C | 0.00 | 316,501 | 0 | 2,437,662 | 2.1 M to 2.4 M (+14.92 %) |
| Jun 19 2020 | MORF | Morphic Holding, I ... | BISCHOFBERGER NORBERT W | Director | Option Exercise | A | 22.96 | 12,000 | 275,520 | 12,000 | |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 9,393 | 0 | 2,317,800 | 2.3 M to 2.3 M (+0.41 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 9,393 | 0 | 19,602 | 29 K to 19.6 K (-32.40 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Payment of Exercise | F | 80.69 | 7,071 | 570,559 | 28,995 | 36.1 K to 29 K (-19.61 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 6,805 | 0 | 36,066 | 29.3 K to 36.1 K (+23.26 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 16,468 | 0 | 29,261 | 12.8 K to 29.3 K (+128.73 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 62.35 | 340 | 21,198 | 12,793 | 12.5 K to 12.8 K (+2.73 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | A | 83.49 | 94,360 | 7,878,116 | 94,360 | |
| Nov 21 2017 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 10,000 | 0 | 2,308,407 | 2.3 M to 2.3 M (-0.43 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 11,558 | 0 | 2,318,407 | 2.3 M to 2.3 M (+0.50 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 11,558 | 0 | 12,453 | 24 K to 12.5 K (-48.14 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Payment of Exercise | F | 70.31 | 7,070 | 497,092 | 24,011 | 31.1 K to 24 K (-22.75 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 3,021 | 0 | 31,081 | 28.1 K to 31.1 K (+10.77 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 5,773 | 0 | 28,060 | 22.3 K to 28.1 K (+25.90 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 59.33 | 315 | 18,689 | 22,287 | 22 K to 22.3 K (+1.43 %) |
| Feb 06 2017 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | A | 72.25 | 104,570 | 7,555,183 | 104,570 | |
| Nov 29 2016 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 10,000 | 0 | 2,306,849 | 2.3 M to 2.3 M (-0.43 %) |
| Aug 26 2016 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 2,800 | 0 | 2,316,849 | 2.3 M to 2.3 M (-0.12 %) |
| Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Payment of Exercise | F | 91.15 | 40,716 | 3,711,263 | 191,940 | 232.7 K to 191.9 K (-17.50 %) |
| Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 52,914 | 0 | 232,656 | 179.7 K to 232.7 K (+29.44 %) |
| Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 14,326 | 0 | 179,742 | 165.4 K to 179.7 K (+8.66 %) |
| Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 76.02 | 248 | 18,854 | 165,416 | 165.2 K to 165.4 K (+0.15 %) |
| Feb 03 2016 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | A | 84.05 | 85,750 | 7,207,288 | 85,750 | |
| Dec 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 23.76 | 43,600 | 1,035,718 | 28,800 | |
| Dec 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 19.09 | 26,400 | 503,844 | 211,600 | |
| Dec 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 102.22 | 39,569 | 4,044,783 | 127,936 | 167.5 K to 127.9 K (-23.62 %) |
| Dec 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 102.66 | 30,431 | 3,123,958 | 167,505 | 197.9 K to 167.5 K (-15.37 %) |
| Dec 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 19.09 | 26,400 | 503,844 | 197,936 | 171.5 K to 197.9 K (+15.39 %) |
| Dec 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 23.76 | 43,600 | 1,035,718 | 171,536 | 127.9 K to 171.5 K (+34.08 %) |
| Nov 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 23.76 | 70,000 | 1,662,850 | 72,400 | |
| Nov 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 103.79 | 5,544 | 575,396 | 165,168 | 170.7 K to 165.2 K (-3.25 %) |
| Nov 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 103.26 | 18,981 | 1,959,881 | 170,712 | 189.7 K to 170.7 K (-10.01 %) |
| Nov 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 102.26 | 45,475 | 4,650,142 | 189,693 | 235.2 K to 189.7 K (-19.34 %) |
| Nov 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 23.76 | 70,000 | 1,662,850 | 235,168 | 165.2 K to 235.2 K (+42.38 %) |
| Nov 13 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 5,000 | 0 | 2,149,681 | 2.2 M to 2.1 M (-0.23 %) |
| Oct 16 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 23.76 | 1,600 | 38,008 | 142,400 | |
| Oct 16 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 23.60 | 68,400 | 1,614,240 | 0 | |
| Oct 16 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 101.18 | 25,319 | 2,561,749 | 165,168 | 190.5 K to 165.2 K (-13.29 %) |
| Oct 16 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 99.96 | 15,376 | 1,537,000 | 190,487 | 205.9 K to 190.5 K (-7.47 %) |
| Oct 16 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 99.25 | 26,105 | 2,590,817 | 205,863 | 232 K to 205.9 K (-11.25 %) |
| Oct 16 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 98.02 | 3,200 | 313,655 | 231,968 | 235.2 K to 232 K (-1.36 %) |
| Oct 16 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 23.76 | 1,600 | 38,008 | 235,168 | 233.6 K to 235.2 K (+0.69 %) |
| Oct 16 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 23.60 | 68,400 | 1,614,240 | 233,568 | 165.2 K to 233.6 K (+41.41 %) |
| Sep 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 23.60 | 70,000 | 1,652,000 | 68,400 | |
| Sep 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 111.56 | 11,802 | 1,316,616 | 165,168 | 177 K to 165.2 K (-6.67 %) |
| Sep 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 110.92 | 41,153 | 4,564,501 | 176,970 | 218.1 K to 177 K (-18.87 %) |
| Sep 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 109.60 | 17,045 | 1,868,077 | 218,123 | 235.2 K to 218.1 K (-7.25 %) |
| Sep 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 23.60 | 70,000 | 1,652,000 | 235,168 | 165.2 K to 235.2 K (+42.38 %) |
| Aug 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 23.60 | 20,000 | 472,000 | 138,400 | |
| Aug 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 21.58 | 50,000 | 1,078,750 | 0 | |
| Aug 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 116.38 | 47,458 | 5,523,020 | 165,168 | 212.6 K to 165.2 K (-22.32 %) |
| Aug 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 115.70 | 22,542 | 2,607,999 | 212,626 | 235.2 K to 212.6 K (-9.59 %) |
| Aug 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 23.60 | 20,000 | 472,000 | 235,168 | 215.2 K to 235.2 K (+9.30 %) |
| Aug 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 21.58 | 50,000 | 1,078,750 | 215,168 | 165.2 K to 215.2 K (+30.27 %) |
| Jul 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 21.58 | 70,000 | 1,510,250 | 50,000 | |
| Jul 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 119.39 | 3,739 | 446,400 | 165,168 | 168.9 K to 165.2 K (-2.21 %) |
| Jul 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 118.72 | 31,767 | 3,771,429 | 168,907 | 200.7 K to 168.9 K (-15.83 %) |
| Jul 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 117.72 | 34,494 | 4,060,723 | 200,674 | 235.2 K to 200.7 K (-14.67 %) |
| Jul 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 21.58 | 70,000 | 1,510,250 | 235,168 | 165.2 K to 235.2 K (+42.38 %) |
| Jun 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 21.58 | 70,000 | 1,510,250 | 120,000 | |
| Jun 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 117.99 | 48,163 | 5,682,497 | 165,168 | 213.3 K to 165.2 K (-22.58 %) |
| Jun 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 116.98 | 21,837 | 2,554,505 | 213,331 | 235.2 K to 213.3 K (-9.29 %) |
| Jun 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 21.58 | 70,000 | 1,510,250 | 235,168 | 165.2 K to 235.2 K (+42.38 %) |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 21.58 | 50,000 | 1,078,750 | 190,000 | |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 20.74 | 20,000 | 414,800 | 0 | |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 109.65 | 43,962 | 4,820,253 | 165,168 | 209.1 K to 165.2 K (-21.02 %) |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 109.12 | 26,038 | 2,841,280 | 209,130 | 235.2 K to 209.1 K (-11.07 %) |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 21.58 | 50,000 | 1,078,750 | 235,168 | 185.2 K to 235.2 K (+27.00 %) |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 20.74 | 20,000 | 414,800 | 185,168 | 165.2 K to 185.2 K (+12.11 %) |
| Apr 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 20.74 | 70,000 | 1,451,800 | 20,000 | |
| Apr 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 103.97 | 59,761 | 6,213,399 | 165,168 | 224.9 K to 165.2 K (-26.57 %) |
| Apr 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 103.06 | 10,239 | 1,055,228 | 224,929 | 235.2 K to 224.9 K (-4.35 %) |
| Apr 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 20.74 | 70,000 | 1,451,800 | 235,168 | 165.2 K to 235.2 K (+42.38 %) |
| Mar 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 20.74 | 50,000 | 1,037,000 | 90,000 | |
| Mar 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.40 | 20,000 | 327,900 | 0 | |
| Mar 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 101.18 | 37,903 | 3,834,938 | 165,168 | 203.1 K to 165.2 K (-18.66 %) |
| Mar 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 100.36 | 32,097 | 3,221,268 | 203,071 | 235.2 K to 203.1 K (-13.65 %) |
| Mar 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 20.74 | 50,000 | 1,037,000 | 235,168 | 185.2 K to 235.2 K (+27.00 %) |
| Mar 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.40 | 20,000 | 327,900 | 185,168 | 165.2 K to 185.2 K (+12.11 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.02 | 500 | 26,010 | 119,394 | 119.9 K to 119.4 K (-0.42 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.03 | 1,600 | 83,248 | 119,894 | 121.5 K to 119.9 K (-1.32 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.04 | 3,800 | 197,752 | 121,494 | 125.3 K to 121.5 K (-3.03 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.05 | 100 | 5,205 | 125,294 | 125.4 K to 125.3 K (-0.08 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.05 | 3,000 | 156,150 | 125,394 | 128.4 K to 125.4 K (-2.34 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.06 | 100 | 5,206 | 128,394 | 128.5 K to 128.4 K (-0.08 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.06 | 6,042 | 314,547 | 128,494 | 134.5 K to 128.5 K (-4.49 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.07 | 100 | 5,207 | 134,536 | 134.6 K to 134.5 K (-0.07 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.07 | 2,628 | 136,840 | 134,636 | 137.3 K to 134.6 K (-1.91 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.08 | 2,630 | 136,970 | 137,264 | 139.9 K to 137.3 K (-1.88 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.09 | 200 | 10,417 | 139,894 | 140.1 K to 139.9 K (-0.14 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.09 | 400 | 20,836 | 140,094 | 140.5 K to 140.1 K (-0.28 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.10 | 1,800 | 93,780 | 140,494 | 142.3 K to 140.5 K (-1.26 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.11 | 1,300 | 67,743 | 142,294 | 143.6 K to 142.3 K (-0.91 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.12 | 200 | 10,424 | 143,594 | 143.8 K to 143.6 K (-0.14 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.13 | 1,500 | 78,195 | 143,794 | 145.3 K to 143.8 K (-1.03 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.14 | 2,300 | 119,922 | 145,294 | 147.6 K to 145.3 K (-1.56 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.15 | 1,300 | 67,795 | 147,594 | 148.9 K to 147.6 K (-0.87 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.16 | 300 | 15,648 | 148,894 | 149.2 K to 148.9 K (-0.20 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.18 | 200 | 10,436 | 149,194 | 149.4 K to 149.2 K (-0.13 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.20 | 1,000 | 52,200 | 1,075,733 | 1.1 M to 1.1 M (-0.09 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.20 | 100 | 5,220 | 1,076,733 | 1.1 M to 1.1 M (-0.01 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.19 | 1,200 | 62,628 | 1,076,833 | 1.1 M to 1.1 M (-0.11 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.18 | 700 | 36,526 | 1,078,033 | 1.1 M to 1.1 M (-0.06 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.17 | 6,900 | 359,973 | 1,078,733 | 1.1 M to 1.1 M (-0.64 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.16 | 2,400 | 125,184 | 1,085,633 | 1.1 M to 1.1 M (-0.22 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.16 | 300 | 15,647 | 1,088,033 | 1.1 M to 1.1 M (-0.03 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.15 | 5,800 | 302,470 | 1,088,333 | 1.1 M to 1.1 M (-0.53 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.15 | 500 | 26,073 | 1,094,133 | 1.1 M to 1.1 M (-0.05 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.14 | 2,800 | 145,992 | 1,094,633 | 1.1 M to 1.1 M (-0.26 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.13 | 5,417 | 282,388 | 1,097,433 | 1.1 M to 1.1 M (-0.49 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.13 | 100 | 5,213 | 1,102,850 | 1.1 M to 1.1 M (-0.01 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.12 | 3,150 | 164,178 | 1,102,950 | 1.1 M to 1.1 M (-0.28 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.12 | 100 | 5,212 | 1,106,100 | 1.1 M to 1.1 M (-0.01 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.11 | 13,151 | 685,299 | 1,106,200 | 1.1 M to 1.1 M (-1.17 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.11 | 300 | 15,632 | 1,119,351 | 1.1 M to 1.1 M (-0.03 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.11 | 1,000 | 52,108 | 1,119,651 | 1.1 M to 1.1 M (-0.09 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.11 | 1,100 | 57,316 | 1,120,651 | 1.1 M to 1.1 M (-0.10 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.10 | 23,866 | 1,243,419 | 1,121,751 | 1.1 M to 1.1 M (-2.08 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.10 | 300 | 15,629 | 1,145,617 | 1.1 M to 1.1 M (-0.03 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 15.27 | 150,000 | 2,289,750 | 453,452 | |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.10 | 1,400 | 72,933 | 1,145,917 | 1.1 M to 1.1 M (-0.12 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.09 | 739 | 38,495 | 1,147,317 | 1.1 M to 1.1 M (-0.06 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.08 | 2,968 | 154,573 | 1,148,056 | 1.2 M to 1.1 M (-0.26 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.08 | 200 | 10,415 | 1,151,024 | 1.2 M to 1.2 M (-0.02 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.08 | 200 | 10,415 | 1,151,224 | 1.2 M to 1.2 M (-0.02 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.07 | 7,852 | 408,854 | 1,151,424 | 1.2 M to 1.2 M (-0.68 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.07 | 400 | 20,826 | 1,159,276 | 1.2 M to 1.2 M (-0.03 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.06 | 6,483 | 337,505 | 1,159,676 | 1.2 M to 1.2 M (-0.56 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.06 | 100 | 5,206 | 1,166,159 | 1.2 M to 1.2 M (-0.01 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.06 | 1,100 | 57,261 | 1,166,259 | 1.2 M to 1.2 M (-0.09 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.05 | 29,749 | 1,548,435 | 1,167,359 | 1.2 M to 1.2 M (-2.49 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.05 | 320 | 16,654 | 1,197,108 | 1.2 M to 1.2 M (-0.03 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.04 | 7,150 | 372,086 | 1,197,428 | 1.2 M to 1.2 M (-0.59 %) |
| May 02 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.04 | 300 | 15,611 | 1,204,578 | 1.2 M to 1.2 M (-0.02 %) |